Hemodynamic Treatment Aimed to Reduce Catecholamine Toxicity in Patients Suffering from Septic Shock: An Observational Single Center Study

References (64)

1. 1 A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study [DOI]
2. 2 Sepsis in European intensive care units: Results of the SOAP study* [DOI]
3. 3 Hemodynamic parameters to guide fluid therapy [DOI]
4. 4 Human Circulation: Regulation During Physical Stress
5. 5 Arginine Vasopressin in Advanced Vasodilatory Shock [DOI]
6. 6 Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy [DOI]
7. 7 Mottling score predicts survival in septic shock [DOI]
8. 8 The prognostic value of the subjective assessment of peripheral perfusion in critically ill patients [DOI]
9. 9 Cardiovascular responses to sustained high skin temperature in resting man. [DOI]
10. 10 Fever Control Using External Cooling in Septic Shock: A Randomized Controlled Trial [DOI]
11. 11 Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents [DOI]
12. 12 Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study [DOI]
13. 13 Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study [DOI]
14. 14 Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial [DOI]
15. 15 Early interventions in severe sepsis and septic shock: a review of the evidence one decade later.
16. 16 The epidemiology of sepsis in Colombia: A prospective multicenter cohort study in ten university hospitals* [DOI]
17. 17 The Effect of Heart Rate Control on Myocardial Ischemia Among High-Risk Patients After Vascular Surgery [DOI]
18. 18 Arginine vasopressin in 316 patients with advanced vasodilatory shock* [DOI]
19. 19 Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve [DOI]
20. 20 Hemodynamic Effects of IV Milrinone Lactate in Pediatric Patients With Septic Shock [DOI]
21. 21 Splanchnic blood flow and metabolism in heat-stressed man. [DOI]
22. 22 Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications* [DOI]
23. 23 Catecholamine‐induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? [DOI]
24. 24 Peripheral vasodilatation determines cardiac output in exercising humans: insight from atrial pacing [DOI]
25. 25 Cardiac performance during vasopressin infusion in postcardiotomy shock [DOI]
26. 26 Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain [DOI]
27. 27 Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: Data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial* [DOI]
28. 28 Low-Dose β-Blocker in Combination With Milrinone Safely Improves Cardiac Function and Eliminates Pulsus Alternans in Patients With Acute Decompensated Heart Failure [DOI]
29. 29 How to protect the heart in septic shock: A hypothesis on the pathophysiology and treatment of septic heart failure [DOI]
30. 30 Assessing the Effect of the Surviving Sepsis Campaign Treatment Guidelines on Clinical Outcomes in a Community Hospital [DOI]
31. 31 Multiple organ failure.
32. 32 Improvement of Postreceptor Events by Metoprolol Treatment in Patients With Chronic Heart Failure [DOI]
33. 33 Regional distribution of blood flow in awake heat-stressed baboons [DOI]
34. 34 Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality [DOI]
35. 35 Risk factors associated with new onset tachyarrhythmias after cardiac surgery – a retrospective analysis [DOI]
36. 36 Relative Toxicity of Cardiotonic Agents: Some Induce More Cardiac and Skeletal Myocyte Apoptosis and Necrosis In Vivo Than Others [DOI]
37. 37 SEPSIS AND SEPTIC SHOCK: PATHOPHYSIOLOGICAL AND CARDIOVASCULAR BACKGROUND AS BASIS FOR THERAPY [DOI]
38. 38 Heart Protection by Combination Therapy with Esmolol and Milrinone at Late-Ischemia and Early Reperfusion [DOI]
39. 39 Current approach to the haemodynamic management of septic shock patients in European intensive care units: a cross-sectional, self-reported questionnaire-based survey [DOI]
40. 40 Comparação dos efeitos da dobutamina e da milrinona sobre a hemodinâmica e o transporte de oxigênio em pacientes submetidos à cirurgia cardíaca com baixo débito cardíaco após indução anestésica [DOI]
41. 41 Epidemiology, Prognosis, and Evolution of Management of Septic Shock in a French Intensive Care Unit: A Five Years Survey [DOI]
42. 42 Role of Heart Rate as a Marker and Mediator of Poor Outcome for Patients with Heart Failure [DOI]
43. 43 Kortikosteroidinsuffizienz bei kritisch Kranken [DOI]
44. 44 Hemodynamic and plasma catecholamine responses to hyperthermic cancer therapy in humans [DOI]
45. 45 PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider [DOI]
46. 46 Chronic β-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-α and IL-1-β in rats [DOI]
47. 47 High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study [DOI]
48. 48 The prognostic association between resting heart rate and cardiac death—Myocardial perfusion defects as a potential mechanism [DOI]
49. 49 Functional antagonism of β‐adrenoceptor subtypes in the catecholamine‐induced automatism in rat myocardium [DOI]
50. 50 Combination of β-Blocker and Milrinone for Acute Heart Failure [DOI]
51. 51 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference [DOI]
52. 52 The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis [DOI]
53. 53 Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress [DOI]
54. 54 Inpatient care for septicemia or sepsis: a challenge for patients and hospitals.
55. 55 Survival in Critical Illness Is Associated with Early Activation of Mitochondrial Biogenesis [DOI]
56. 56 Functional hemodynamic monitoring. [DOI]
57. 57 Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients [DOI]
58. 58 Causes of death and determinants of outcome in critically ill patients [DOI]
59. 59 Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock* [DOI]
60. 60 Milrinone Use Is Associated With Postoperative Atrial Fibrillation After Cardiac Surgery [DOI]
61. 61 Clinical review: Guyton - the role of mean circulatory filling pressure and right atrial pressure in controlling cardiac output [DOI]
62. 62 Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression [DOI]
63. 63 Microvascular dysfunction in the surgical patient [DOI]
64. 64 Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Epidemiological Analysis of Infective Endocarditis at the Gold Coast Area Health Service, Australia — shares topic coverage
• Analysis of Patients Who Died Following Hartmann’s Procedure — shares topic coverage
• Is Caesarean Delivery Safe? Experience from a Low Resource Setting — shares topic coverage
• Acute Kidney Injury in Hospitalised Medical Patients: Aetiology and Prognosis — shares topic coverage
• Gender-Related Differences and Mortality Predictors among Egyptian Hemodialysis Patients: A Multi-Center Prospective Observational Study — shares topic coverage